Bradley A. Maron
Co-Executive Director, University of Maryland-Institute for Health Computing · University of Maryland-Institute for Health Computing
Credentials: · ·
History
PresentPulmonary Hypertension Program · University of Maryland School of Medicine
- Present
Precision Medicine · University of Maryland School of Medicine
Research
Genetic Misdiagnoses and the Potential for Health Disparities
New England Journal of Medicine · 2016 · 596 citations
Circulation · 2016 · First of 20 authors · Corresponding · 329 citations
Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity
Nature Medicine · 2007 · 286 citations
37 papers
- JL
33 papers
20 papers
20 papers
19 papers
18 papers
16 papers
14 papers
Grants
- 2018–2027
National Heart, Lung, and Blood Institute · R01
Contact PI · $4.1M · University of Maryland Baltimore
- 2022–2027
National Heart, Lung, and Blood Institute · R01
PI · $3.4M · Vanderbilt University Medical Center
- 2021–2026
Personalized Protein-Protein Interactomes and Precision Medicine in Pulmonary Arterial Hypertension
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.6M · University of Maryland Baltimore
- 2020–2025
NEDD9-SMAD3, Fibrinolysis, and Chronic Thromboembolic Pulmonary Hypertension
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.7M · University of Maryland Baltimore
Clinical trials
- 2015–2018
The Combination Ambrisentan Plus Spironolactone in Pulmonary Arterial Hypertension Study
Principal investigator · Terminated · Phase 4
Brigham and Women's Hospital